Verification of the Efficacy and Safety of the BAROSTIM NEO System in the Treatment of Drug Resistant Hypertension
Condition(s):High Blood PressureLast Updated:February 7, 2024Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):High Blood PressureLast Updated:February 7, 2024Active, not recruiting
Condition(s):Coronary Artery Disease; Collateral Circulation; IschemiaLast Updated:January 16, 2014Completed
Condition(s):Arterial Spasm; Coronary Artery DiseaseLast Updated:December 7, 2023Recruiting
Condition(s):Endothelial DysfunctionLast Updated:November 17, 2010Completed
Condition(s):Obesity, Morbid; Ischemic Heart DiseaseLast Updated:May 6, 2016Terminated
Condition(s):Cardiovascular Diseases; Coronary Disease; Heart Diseases; Myocardial IschemiaLast Updated:March 25, 2016Completed
Condition(s):Pulmonary Edema; Dyspnea; Paroxysmal; Congestive Heart FailureLast Updated:March 30, 2010Completed
Condition(s):Hypertension; Heart FailureLast Updated:August 29, 2014Completed
Condition(s):Stable Angina; Heart Failure; Atherosclerosis; Multivessel Coronary Artery DiseaseLast Updated:March 17, 2021Completed
Condition(s):Patient Engagement; Medication Optimization; Heart Failure With Reduced Ejection Fraction; Patient ActivationLast Updated:October 6, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.